CLINICAL_TRIALS
trial_result
· 2021-12-13
Clinical Trial Update: Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough [Phase 2]
Summary
Phase 2 trial updating on efficacy and safety of BLU-5937 in adults with refractory chronic cough.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bellus Health Inc. - a GSK company | Conditions: Refractory Chronic Cough | Phase 2 | Status: COMPLETED